Perceptions and acceptability of piloted Taenia solium control and elimination interventions in two endemic communities in eastern Zambia.
Adolescent
Adult
Animals
Anthelmintics
/ therapeutic use
Antibodies, Helminth
/ blood
Communicable Disease Control
Cysticercosis
/ epidemiology
Endemic Diseases
/ prevention & control
Feces
/ parasitology
Female
Humans
Male
Niclosamide
/ therapeutic use
Patient Acceptance of Health Care
/ psychology
Patient Participation
/ psychology
Pilot Projects
Praziquantel
/ therapeutic use
Public Health
Surveys and Questionnaires
Swine
Swine Diseases
/ epidemiology
Taenia solium
/ isolation & purification
Young Adult
Zambia
/ epidemiology
Taenia solium
communicable disease control
focus groups
parasites
public health
surveys and questionnaires
Journal
Transboundary and emerging diseases
ISSN: 1865-1682
Titre abrégé: Transbound Emerg Dis
Pays: Germany
ID NLM: 101319538
Informations de publication
Date de publication:
Jul 2020
Jul 2020
Historique:
received:
14
11
2018
revised:
04
04
2019
accepted:
08
04
2019
pubmed:
25
6
2019
medline:
31
10
2020
entrez:
25
6
2019
Statut:
ppublish
Résumé
Infections with Taenia solium cause significant public health and economic losses worldwide. Despite effective control tools, long-term sustained control/elimination of the parasite has not been demonstrated to date. Success of intervention programs is dependent on their acceptability to local communities. Focus group discussions (FGDs) and questionnaires (QS) were conducted in two study communities in eastern Zambia to assess local perceptions and acceptance of two piloted intervention strategies: one targeting pigs only ('control' study arm), and one integrated human- and pig-based ('elimination') strategy. QS (n = 227) captured data regarding participation in project activities, knowledge and perceptions of T. solium and of the interventional drugs used in the study. FGDs (n = 18) discussed perceived advantages and disadvantages of the interventions and of the project's delivery and value. QS data revealed 67% of respondents participated in at least one educational activity, and 80% correctly identified at least one disease targeted by the education. All elimination study arm respondents (n = 113) had taken the human treatment, and 98% intended to do so next time. Most (70%) indicated willingness to pay for future treatments (median 0.20 USD per dose). Of pig-owning respondents, 11/12 (92%) had allowed their pigs to be treated/vaccinated and all intended to do so again next time. Four pig owners indicated willingness to pay 0.10-0.50 USD per dose of treatment or vaccine. FGD feedback revealed positive perceptions of interventions; people reported improved health in themselves and their pigs, and fewer cysticerci in pork. Latrine use, hand washing, meat inspection and proper cooking of pork had reportedly increased since the program's inception. Preliminary assessment indicates that the piloted intervention methods are generally acceptable to the communities. The reported willingness of many respondents to pay for the medications would contribute to the feasibility of long-term, government-led T. solium intervention programs in future.
Identifiants
pubmed: 31231968
doi: 10.1111/tbed.13214
pmc: PMC7496623
doi:
Substances chimiques
Anthelmintics
0
Antibodies, Helminth
0
Praziquantel
6490C9U457
Niclosamide
8KK8CQ2K8G
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
69-81Informations de copyright
© 2019 The Authors. Transboundary and Emerging Diseases published by Blackwell Verlag GmbH.
Références
Int J Parasitol. 2010 Aug 15;40(10):1183-92
pubmed: 20470777
Neuropediatrics. 2015 Oct;46(5):354-5
pubmed: 26308218
Vet Parasitol. 2018 Feb 15;251:63-67
pubmed: 29426478
Am J Trop Med Hyg. 1997 Feb;56(2):127-32
pubmed: 9080868
Trans R Soc Trop Med Hyg. 2000 Jan-Feb;94(1):85-9
pubmed: 10748908
Acta Trop. 2003 Jun;87(1):111-7
pubmed: 12781385
PLoS Negl Trop Dis. 2013 Apr 25;7(4):e1964
pubmed: 23638190
PLoS Negl Trop Dis. 2012;6(5):e1651
pubmed: 22666509
Alcohol Res Health. 2011;34(2):135-43
pubmed: 22330211
PLoS Med. 2015 Dec 03;12(12):e1001920
pubmed: 26633705
N Engl J Med. 2016 Jun 16;374(24):2335-44
pubmed: 27305193
Vet Parasitol. 2016 Jul 30;225:33-42
pubmed: 27369573
Trop Med Int Health. 2018 Mar;23(3):306-314
pubmed: 29314480
Int J Parasitol. 2004 Apr;34(5):569-76
pubmed: 15064121
PLoS Negl Trop Dis. 2013;7(3):e2142
pubmed: 23556026
Acta Trop. 2017 Jan;165:240-245
pubmed: 26536396
Lancet Glob Health. 2018 Apr;6(4):e411-e425
pubmed: 29530423
PLoS Negl Trop Dis. 2015 Mar 04;9(3):e0003570
pubmed: 25739017
PLoS Negl Trop Dis. 2019 May 20;13(5):e0007336
pubmed: 31107880
Soc Sci Med. 2014 Nov;120:215-23
pubmed: 25261615
PLoS Negl Trop Dis. 2012;6(3):e1594
pubmed: 22479664
PLoS Negl Trop Dis. 2016 Dec 16;10(12):e0005184
pubmed: 27984581
Transbound Emerg Dis. 2020 Jul;67 Suppl 2:69-81
pubmed: 31231968
Lancet Neurol. 2014 Dec;13(12):1202-15
pubmed: 25453460
Acta Trop. 2017 Oct;174:171-178
pubmed: 26001973